Advertisement

Topics

Calcitonin Gene Related Peptide CGRP Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

13:01 EDT 14 Mar 2018 | BioPortfolio Report Blog

Calcitonin Gene Related Peptide CGRP Pipeline Review, H1 2018


Summary


According to the recently published report 'Calcitonin Gene Related Peptide CGRP Pipeline Review, H1 2018'; Calcitonin Gene Related Peptide CGRP pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies.


Calcitonin Gene Related Peptide CGRP Calcitonin gene related peptide CGRP is a member of the calcitonin family of peptides. It exists in two forms alphaCGRP and betaCGRP. CGRP is produced in both peripheral and central neurons. CGRP is derived mainly from the cell bodies of motor neurons when synthesized in the ventral horn of the spinal cord and contribute to the regeneration of nervous tissue after injury.


CGRP is derived from dorsal root ganglion when synthesized in the dorsal horn of the spinal cord and linked to the transmission of pain. CGRP also plays an important role in cardiovascular homeostasis and nociception.


The report 'Calcitonin Gene Related Peptide CGRP Pipeline Review, H1 2018' outlays comprehensive information on the Calcitonin Gene Related Peptide CGRP targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.


It also reviews key players involved in Calcitonin Gene Related Peptide CGRP targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in PreRegistration, Phase III, Preclinical and Discovery stages are 2, 1, 2 and 2 respectively. Report covers products from therapy areas Central Nervous System which include indications Migraine, Cluster Headache Syndrome, Dental Pain, Inflammatory Pain, Osteoarthritis Pain and Pain.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Calcitonin Gene Related Peptide CGRP

The report reviews Calcitonin Gene Related Peptide CGRP targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Calcitonin Gene Related Peptide CGRP targeted therapeutics and enlists all their major and minor projects

The report assesses Calcitonin Gene Related Peptide CGRP targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Calcitonin Gene Related Peptide CGRP targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Calcitonin Gene Related Peptide CGRP

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Calcitonin Gene Related Peptide CGRP development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Calcitonin Gene Related Peptide CGRP Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Calcitonin Gene Related Peptide CGRP Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...